- Home
- NNBR vs CDXS Comparison
NNBR vs CDXS Comparison
Compare NNBR & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNBR
- CDXS
- Stock Information
- Founded
- NNBR 1980
- CDXS 2002
- Country
- NNBR United States
- CDXS United States
- Employees
- NNBR N/A
- CDXS N/A
- Industry
- NNBR Industrial Machinery/Components
- CDXS Major Chemicals
- Sector
- NNBR Industrials
- CDXS Industrials
- Exchange
- NNBR Nasdaq
- CDXS Nasdaq
- Market Cap
- NNBR 149.8M
- CDXS 176.4M
- IPO Year
- NNBR 1994
- CDXS 2010
- Fundamental
- Price
- NNBR $1.71
- CDXS $2.46
- Analyst Decision
- NNBR
- CDXS Buy
- Analyst Count
- NNBR 0
- CDXS 2
- Target Price
- NNBR N/A
- CDXS $11.00
- AVG Volume (30 Days)
- NNBR 196.9K
- CDXS 500.7K
- Earning Date
- NNBR 05-07-2025
- CDXS 05-14-2025
- Dividend Yield
- NNBR N/A
- CDXS N/A
- EPS Growth
- NNBR N/A
- CDXS N/A
- EPS
- NNBR N/A
- CDXS N/A
- Revenue
- NNBR $448,780,000.00
- CDXS $59,345,000.00
- Revenue This Year
- NNBR $0.82
- CDXS $12.62
- Revenue Next Year
- NNBR $6.29
- CDXS $22.11
- P/E Ratio
- NNBR N/A
- CDXS N/A
- Revenue Growth
- NNBR N/A
- CDXS N/A
- 52 Week Low
- NNBR $1.58
- CDXS $1.90
- 52 Week High
- NNBR $4.67
- CDXS $6.08
- Technical
- Relative Strength Index (RSI)
- NNBR 38.01
- CDXS 51.79
- Support Level
- NNBR $1.76
- CDXS $2.23
- Resistance Level
- NNBR $1.99
- CDXS $2.59
- Average True Range (ATR)
- NNBR 0.15
- CDXS 0.14
- MACD
- NNBR 0.01
- CDXS 0.05
- Stochastic Oscillator
- NNBR 20.45
- CDXS 70.45
About NNBR NN Inc.
NN Inc is a diversified industrial company that combines engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision solutions and components. It operates in two business segments: mobile solutions and power solutions. The mobile solutions segment involves growth in the general industrial and automotive end markets. Its power solutions segment involves growth in the electrical and aerospace and defense end markets. It also operates in China, Mexico, Brazil, Germany, and other countries.
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.